These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

938 related items for PubMed ID: 30317791

  • 1. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
    Liu MH, Zhou F, Wang XB, Chen LP, Li GZ, Zhao Q.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug 20; 26(8):596-600. PubMed ID: 30317791
    [Abstract] [Full Text] [Related]

  • 2. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH, Chu JG, Huang H, Zhao GR, Yao KC.
    World J Gastroenterol; 2019 Mar 07; 25(9):1088-1099. PubMed ID: 30862997
    [Abstract] [Full Text] [Related]

  • 3. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D, Zuo H, Liu L, Dong J, Ding L.
    Virol J; 2018 Oct 01; 15(1):151. PubMed ID: 30285813
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP, Chen SL, Wang JY, Liu F, Tan Q, Peng QF, Zhao JB.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug 20; 28(8):672-678. PubMed ID: 32911906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].
    Jiang MM, Xu H, Zhang QQ, Wei N, Xu W, Cui YF, Liu HT, Zu MH, Wang WL, Gao ZK.
    Zhonghua Yi Xue Za Zhi; 2019 Dec 17; 99(47):3737-3740. PubMed ID: 31874500
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases].
    Zhou H, Yao X, Tang SH, Xie M, Feng ZS, Qin JP.
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan 20; 29(1):54-59. PubMed ID: 33541024
    [Abstract] [Full Text] [Related]

  • 8. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH, Zhou MM, Cai MJ, Han SL, Zhang XQ, Chu JG.
    World J Gastroenterol; 2023 Apr 21; 29(15):2336-2348. PubMed ID: 37124886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ.
    Hepatobiliary Pancreat Dis Int; 2018 Dec 21; 17(6):517-523. PubMed ID: 30262421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.
    Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M.
    World J Gastroenterol; 2013 Nov 28; 19(44):8085-92. PubMed ID: 24307804
    [Abstract] [Full Text] [Related]

  • 14. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H.
    Ugeskr Laeger; 2003 Jan 27; 165(5):439-42. PubMed ID: 12599838
    [Abstract] [Full Text] [Related]

  • 15. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
    He FL, Wang L, Yue ZD, Zhao HW, Liu FQ.
    World J Gastroenterol; 2014 Sep 07; 20(33):11835-9. PubMed ID: 25206289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F, Strassburg CP, Trautwein C, Sauerbruch T, Wasmuth HE, Trebicka J.
    J Hepatol; 2015 Feb 07; 62(2):332-9. PubMed ID: 25457205
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.